<?xml version="1.0" encoding="UTF-8"?>
<p>Hyperglycemia is a major cause of diabetes-associated neuronal diseases through cellular senescence. Cellular senescence is the process of an irreversible cell cycle arrest through many mechanisms, that is, inflammation cytokine, oxidative stress and cell cycle checkpoint [
 <xref rid="B104-pharmaceuticals-13-00283" ref-type="bibr">104</xref>,
 <xref rid="B105-pharmaceuticals-13-00283" ref-type="bibr">105</xref>,
 <xref rid="B106-pharmaceuticals-13-00283" ref-type="bibr">106</xref>]. Further, it causes many age-related chronic diseases such as atherosclerosis, Alzheimerâ€™s disease and cancer [
 <xref rid="B107-pharmaceuticals-13-00283" ref-type="bibr">107</xref>,
 <xref rid="B108-pharmaceuticals-13-00283" ref-type="bibr">108</xref>,
 <xref rid="B109-pharmaceuticals-13-00283" ref-type="bibr">109</xref>,
 <xref rid="B110-pharmaceuticals-13-00283" ref-type="bibr">110</xref>,
 <xref rid="B111-pharmaceuticals-13-00283" ref-type="bibr">111</xref>]. The antidiabetic and antioxidant activity of CH and its phytochemical constituents was described earlier in human adipocytes, cataract in streptozotocin-induced diabetic rats [
 <xref rid="B112-pharmaceuticals-13-00283" ref-type="bibr">112</xref>] and hepatoprotective effect in paracetamol-induced injury in rats [
 <xref rid="B23-pharmaceuticals-13-00283" ref-type="bibr">23</xref>]. However, the exact pathway of protective effect of CH on high glucose-induced neuronal senescence was not explored.
</p>
